Related Experiment Video

Updated: Jul 5, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders

D-A Landau1, M Rosenzwajg, D Saadoun

  • 1Laboratoire de Biologie et Thérapeutique des Pathologies Immunitaires, Centre National de la Recherche Sientifique, Universite Pierre et Marrie Curie UMR 7087, Paris, France.

Annals of the Rheumatic Diseases
|April 25, 2008
PubMed

Insights

Increased B lymphocyte stimulator (BLyS) activity is linked to hepatitis C virus (HCV)-induced B cell disorders. Targeting the BLyS receptor-ligand system may offer new therapeutic strategies for these conditions.

Area of Science:

  • Immunology
  • Virology
  • Hematology

Background:

  • Hepatitis C virus (HCV) infection is associated with various B cell abnormalities.
  • B lymphocyte stimulator (BLyS) plays a crucial role in B cell survival and function.
  • Dysregulation of the BLyS system may contribute to HCV-related B cell clonal disorders.

Purpose of the Study:

  • To investigate the B lymphocyte stimulator (BLyS) receptor-ligand system in patients with chronic hepatitis C virus (HCV) infection.
  • To determine the association between BLyS system alterations and HCV-induced B cell clonal disorders, including mixed cryoglobulinaemia (MC)-vasculitis and B cell non-Hodgkin's lymphoma (B-NHL).

Main Methods:

  • Serum BLyS levels and membrane BLyS expression were analyzed in 94 chronic HCV patients (including those with MC-vasculitis and B-NHL) and 15 healthy controls.
  • Flow cytometry was used to assess CD19+ B cell BLyS binding and BLyS receptor 3 (BR3) staining.
  • Changes in BLyS and BR3 were evaluated in relation to disease status, antiviral treatment, and rituximab therapy.

Main Results:

  • Serum BLyS was significantly elevated in HCV-induced MC-vasculitis (twofold) and B-NHL (threefold) compared to controls.
  • Decreased membrane BLyS expression and stepwise reduction in CD19+ BLyS binding and BR3 staining were observed in patients with HCV-related B cell disorders, particularly B-NHL.
  • Antiviral treatment led to decreased serum BLyS and increased BR3 staining, correlating with clinical remission.
  • Rituximab treatment caused a transient increase in serum BLyS, followed by decreased BR3 staining in repopulating B cells.

Conclusions:

  • The BLyS ligand-receptor system is dysregulated in HCV-induced B cell clonal disorders.
  • Elevated BLyS activity and altered receptor expression suggest a role in the pathogenesis of these conditions.
  • Targeting the BLyS pathway represents a potential therapeutic strategy for HCV-associated B cell lymphoproliferative disorders.
Abstract

More Related Videos

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...